A Novel Auditory Application for Distraction in Pediatric Patients
Status
Conditions
Treatments
Details and patient eligibility
About
This mixed-methods study seeks to evaluate the feasibility of Mystic Pets software and hardware within the pediatric population. This study will take place at Lucile Packard Children's Hospital (Stanford University, Palo Alto, CA).
Full description
Hospitalized children often experience emotional distress related to medical procedures, unfamiliar environments, and limited control over their situations. Existing distraction techniques, such as traditional videos and gaming, often rely heavily on visual interfaces, which can be limiting in clinical contexts. Current immersive technology software and hardware for procedural distraction rely on partial to complete immersion in a computer-generated environment to the real world. While immersive technology can reduce emotional distress with distraction, some patients experience increased distress due to loss of visual connection with their surroundings and/or caregivers. Using a head-mounted device and hand-gesture inputs, Mystic Pets maintains visual contact with a person's surroundings while gameplay is advanced through audio input and hand-gestures.
This research will significantly contribute to the growing field of digital therapeutics by providing early-stage data on a novel, immersive technology tailored to pediatric clinical care. If proven feasible, Mystic Pets could expand the toolkit available for procedural distraction, enhance patient comfort, and reduce the reliance on pharmacological interventions for emotion distress management.
The study also aims to establish preliminary engagement and usability benchmarks to guide future development and deployment of similar technologies in hospital environments.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Between 4-17 years
- English speaking participants
Exclusion criteria
- Legal guardian not present to obtain consent
- Child with hearing impairment
- Child with a significant neurological condition, or major developmental disability
- Child with facial abnormalities or injuries prohibiting use of headsets
- Nausea at the time of recruitment,
- A history of severe motion sickness,
- A history of seizures
Trial design
Primary purpose
Allocation
Interventional model
Masking
20 participants in 1 patient group
Trial contacts and locations
Loading...
Central trial contact
Thomas Caruso, MD, PhD; Man Yee Suen, MMedSc
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal